Search by Drug Name or NDC

    NDC 00363-2529-67 Bronchial Asthma Relief 12.5; 200 mg/1; mg/1 Details

    Bronchial Asthma Relief 12.5; 200 mg/1; mg/1

    Bronchial Asthma Relief is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Walgreen Company. The primary component is EPHEDRINE HYDROCHLORIDE; GUAIFENESIN.

    Product Information

    NDC 00363-2529
    Product ID 0363-2529_bcb71dc3-3e98-de10-e053-2a95a90a41ac
    Associated GPIs 43996202050320
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Bronchial Asthma Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ephedrine HCl, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 12.5; 200
    Active Ingredient Units mg/1; mg/1
    Substance Name EPHEDRINE HYDROCHLORIDE; GUAIFENESIN
    Labeler Name Walgreen Company
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Norepinephrine Activity [PE], Increased Respiratory Secretions [PE], Norepinephrine Releasing Agent [EPC], alpha-
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 00363-2529-67 (00363252967)

    NDC Package Code 0363-2529-67
    Billing NDC 00363252967
    Package 4 BLISTER PACK in 1 CARTON (0363-2529-67) / 15 TABLET in 1 BLISTER PACK
    Marketing Start Date 2002-02-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 10816e9d-0c53-424b-b482-fdd01a4d8525 Details

    Revised: 11/2022